Craneware plc

("Craneware" or the "Company" or the "Group")

Total Voting Rights

22 October 2025 - Following recent share option exercise transactions by employees, the Company has transferred Ordinary Shares previously held in treasury to satisfy those share option exercise transactions.

As a result, the Company's issued share capital now consists of 35,542,169 Ordinary Shares, of which 110,302 remain held in treasury. Accordingly, the total number of Ordinary Shares in the Company with voting rights is 35,431,867. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

Craneware plc                                                                                         +44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

Alma Strategic Communications                                                          +44 (0)20 3405 0205

Caroline Forde, Kinvara Verdon, Sarah Peters                                        craneware@almastrategic.com

Peel Hunt (NOMAD and Joint Broker)                                                  +44 (0)20 7418 8900

Neil Patel, Benjamin Cryer, Kate Bannatyne

Investec Bank PLC (Joint Broker)                                                        +44 (0)20 7597 5970

Patrick Robb, Virginia Bull, James Smith

Berenberg (Joint Broker)                                                                      +44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Patrick Dologhan

About Craneware

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus^® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.

Learn more at www.thecranewaregroup.com